Tsutomu Takahashi1*, Ritsuro Suzuki2*, Hiroyasu Ogawa, MD, PhD3, Takahiro Fukuda, MD4*, Kazuteru Ohashi5, Shuichi Taniguchi6, Yoshinobu Kanda, MD, PhD7, Hiromasa Abe8*, Yoshihisa Kodera, MD9 and Junji Suzumiya, MD, PhD1
1Department of Oncology/Hematology, Shimane University Hospital Cancer Center, Izumo, Japan
2Oncology/Haematology, Shimane University Hospital Cancer Center, Izumo, Japan
3Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
4Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
5Department of Hematology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan
6Department of Hematology, Toranomon Hospital, Tokyo, Japan
7Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
8Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Sagamihara, Japan
9Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan